Antimicrobial activity of fibrinogen and fibrinogen-derived peptides – a novel link between coagulation and innate immunity

Summary

Fibrinogen is a key player in the blood coagulation system, and is upon activation with thrombin converted into fibrin that subsequently forms a fibrin clot. In the present study, we investigated the role of fibrinogen in the early innate immune response. Here we show that the viability of fibrinogen-binding bacteria is affected in human plasma activated with thrombin. Moreover, we found that the peptide fragment GHR28 released from the p-chain of fibrinogen has antimicrobial activity against bacteria that bind fibrinogen to their surface, whereas non-binding strains are unaffected. Notably, bacterial killing was detected in Group A Streptococcus bacteria entrapped in a fibrin clot, suggesting that fibrinogen and coagulation is involved in the early innate immune system to quickly wall off and neutralise invading pathogens.

Keywords

Innate immunity - coagulation - fibrinogen - infection

• References

• 1 Loof TG, Schmidt O, Herwald H. et al. Coagulation systems of invertebrates and vertebrates and their roles in innate immunity: the same side of two coins?. J Innate Immun 2011; 03: 34-40.
• 2 Nordahl EA, Rydengard V, Morgelin M. et al. Domain 5 of high molecular weight kininogen is antibacterial. J Biol Chem 2005; 280: 34832-34839.
• 3 Frick IM, Akesson P, Herwald H. et al. The contact system--a novel branch of innate immunity generating antibacterial peptides. Embo J 2006; 25: 5569-5578.
• 4 Papareddy P, Rydengard V, Pasupuleti M. et al. Proteolysis of human thrombin generates novel host defense peptides. PLoS Pathog 2010; 06: e1000857.
• 5 Loof TG, Morgelin M, Johansson L. et al. Coagulation, an ancestral serine protease cascade, exerts a novel function in early immune defense. Blood 2011; 118: 2589-2598.
• 6 Wang Z, Wilhelmsson C, Hyrsl P. et al. Pathogen entrapment by transglutaminase--a conserved early innate immune mechanism. PLoS Pathog 2010; 06: e1000763.
• 7 Kihlberg BM, Collin M, Olsen A. et al. Protein H, an antiphagocytic surface protein in Streptococcus pyogenes. Infect Immun 1999; 67: 1708-1714.
• 8 Kantor FS. Fibrinogen Precipitation by Streptococcal M Protein. I. Identity of the Reactants, and Stoichiometry of the Reaction. J Exp Med 1965; 121: 849-859.
• 9 Rivera J, Vannakambadi G, Hook M. et al. Fibrinogen-binding proteins of Gram-positive bacteria. Thromb Haemost 2007; 98: 503-511.
• 10 Ben Nasr A, Olsen A, Sjobring U. et al. Assembly of human contact phase proteins and release of bradykinin at the surface of curli-expressing Escherichia coli. Mol Microbiol 1996; 20: 927-935.
• 11 Jennewein C, Tran N, Paulus P. et al. Novel aspects of fibrin(ogen) fragments during inflammation. Mol Med 2011; 17: 568-573.
• 12 Andersson E, Rydengard V, Sonesson A. et al. Antimicrobial activities of heparin-binding peptides. Eur J Biochem 2004; 271: 1219-1226.
• 13 Senior RM, Skogen WF, Griffin GL. et al. Effects of fibrinogen derivatives upon the inflammatory response. Studies with human fibrinopeptide B. J Clin Invest 1986; 77: 1014-1019.
• 14 Richardson DL, Pepper DS, Kay AB. Chemotaxis for human monocytes by fibrinogen-derived peptides. Br J Haematol 1976; 32: 507-513.
• 15 Davalos D, Akassoglou K. Fibrinogen as a key regulator of inflammation in disease. Semin Immunopathol 2012; 34: 43-62.
• 16 Smiley ST, King JA, Hancock WW. Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4. J Immunol 2001; 167: 2887-2894.
• 17 Engelmann B, Massberg S. Thrombosis as an intravascular effector of innate immunity. Nat Rev Immunol 2013; 13: 34-45.
• 18 Cerenius L, Soderhall K. Coagulation in invertebrates. J Innate Immun 2011; 03: 3-8.
• 19 Hanington PC, Zhang SM. The primary role of fibrinogen-related proteins in invertebrates is defense, not coagulation. J Innate Immun 2011; 03: 17-27.
• 20 Fan C, Zhang S, Li L. et al. Fibrinogen-related protein from amphioxus Branchiostoma belcheri is a multivalent pattern recognition receptor with a bacteriolytic activity. Mol Immunol 2008; 45: 3338-3346.
• 21 Tapper H, Herwald H. Modulation of hemostatic mechanisms in bacterial infectious diseases. Blood 2000; 96: 2329-2337.
• 22 Davis SL, Gurusiddappa S, McCrea KW. et al. SdrG, a fibrinogen-binding bacterial adhesin of the microbial surface components recognising adhesive matrix molecules subfamily from Staphylococcus epidermidis, targets the thrombin cleavage site in the Bbeta chain. J Biol Chem 2001; 276: 27799-27805.
• 23 Nilsson M, Frykberg L, Flock JI. et al. A fibrinogen-binding protein of Staphylococcus epidermidis. Infect Immun 1998; 66: 2666-2673.
• 24 Sellman BR, Timofeyeva Y, Nanra J. et al. Expression of Staphylococcus epidermidis SdrG increases following exposure to an in vivo environment. Infect Immun 2008; 76: 2950-2957.
• 25 McCrea KW, Hartford O, Davis S. et al. The serine-aspartate repeat (Sdr) protein family in Staphylococcus epidermidis. Microbiology 2000; 146: 1535-1546.
• 26 Risley AL, Loughman A, Cywes-Bentley C. et al. Capsular polysaccharide masks clumping factor A-mediated adherence of Staphylococcus aureus to fibrinogen and platelets. J Infect Dis 2007; 196: 919-927.
• 27 Siboo IR, Cheung AL, Bayer AS. et al. Clumping factor A mediates binding of Staphylococcus aureus to human platelets. Infect Immun 2001; 69: 3120-3127.
• 28 Josefsson E, Hartford O, O’Brien L. et al. Protection against experimental Staphylococcus aureus arthritis by vaccination with clumping factor A, a novel virulence determinant. J Infect Dis 2001; 184: 1572-1580.
• 29 McAdow M, Missiakas DM, Schneewind O. Staphylococcus aureus secretes coagulase and von Willebrand factor binding protein to modify the coagulation cascade and establish host infections. J Innate Immun 2012; 04: 141-148.
• 30 McAdow M, Kim HK, Dedent AC. et al. Preventing Staphylococcus aureus sepsis through the inhibition of its agglutination in blood. PLoS Pathog 2011; 07: e1002307.
• 31 Flick MJ, Du X, Witte DP. et al. Leukocyte engagement of fibrin(ogen) via the integrin receptor alphaMbeta2/Mac-1 is critical for host inflammatory response in vivo. J Clin Invest 2004; 113: 1596-1606.